Показано 0 из 0
Дата |
---|
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
5.88
|
6.55
|
6.67
|
6.025
|
6.77
|
6.06
|
|
|
8 147 421.62
|
12 033.00
|
6.50
|
8.44
|
6.80
|
6.60
|
7.09
|
6.69
|
|
|
6 214 561.11
|
8 413.00
|
6.80
|
7.14
|
6.93
|
6.78
|
7.19
|
6.80
|
|
|
7 102 508.91
|
13 810.00
|
6.50
|
6.68
|
6.46
|
6.45
|
6.72
|
6.70
|
|
|
7 369 059.62
|
10 805.00
|
6.00
|
6.50
|
6.34
|
6.22
|
6.56
|
6.34
|
|
|
5 024 639.76
|
7 567.00
|
2.53
|
6.32
|
6.66
|
6.26
|
6.88
|
6.30
|
|
|
6 189 721.66
|
8 474.00
|
6.57
|
6.62
|
6.87
|
6.58
|
6.87
|
6.60
|
|
|
7 990 262.97
|
8 841.00
|
6.69
|
6.84
|
6.74
|
6.49
|
6.935
|
6.82
|
|
|
8 283 684.33
|
15 416.00
|
6.75
|
7.00
|
7.40
|
6.74
|
7.69
|
6.75
|
|
|
13 674 723.23
|
17 343.00
|
6.75
|
6.79
|
6.27
|
6.21
|
6.575
|
6.55
|
|
|
8 956 010.35
|
12 507.00
|
Retrophin Inc. (Retrophin), formerly Desert Gateway, Inc., is a biotechnology company. The Company focused on discovering and developing treatments for rare and life-threatening diseases. The Company is developing treatments for Focal Segmental Glomerulosclerosis (FSGS), Pantothenate Kinase-Associated Neurodegeneration (PKAN), Duchenne Muscular Dystrophy and other catastrophic diseases.